Diclona Gel
Product Images NDC 68788-4013

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclona (NDC 68788-4013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

A Close-up Of A Yellow And Black Documentai-generated Content May Be Incorrect. (Diclona Box 053124 (1))

A Close-up Of A Yellow And Black Documentai-generated Content May Be Incorrect. (Diclona Box 053124 (1))
This text appears to describe a medication called Diclona, which is a gel containing Lidocaine HCI 4.5% and Diclofenac Sodium 1%. The gel is used as a topical anesthetic and as a pain reliever for arthritis. It emphasizes the importance of following prescription guidelines and keeping the medication out of children's reach. The manufacturer is Clinic Pharma, and it provides instructions for storage and usage of the gel.*
FDA Label Image

Back (Diclona Package Insert Gsc 102424 Back (1))

Back (Diclona Package Insert Gsc 102424 Back (1))
"Diclona™ is a medication indicated for pain relief associated with various conditions such as arthritis, backache, cramps, and strains. It should be applied only on intact skin, and sun exposure should be avoided during therapy. However, there are contraindications and warnings regarding its use, including the risk of serious cardiovascular events and methemoglobinemia linked with lidocaine use. Patients are advised to seek immediate medical attention if symptoms like pale or blue-colored skin, headache, rapid heart rate, shortness of breath, lightheadedness, or fatigue occur. Specific drug interactions and precautions are also outlined to ensure safe usage of Diclona™."*
FDA Label Image

Package Insert (Front)

Package Insert (Front)
Diclona™ is a gel medication containing 4.5% Lidocaine and 1% Diclofenac Sodium, used for topical application to achieve pain relief. It is advised to clean and dry the affected area before applying up to 4 times daily. If irritation occurs, wash off the product and wait until the irritation subsides before reapplying. The product should be kept out of reach of children and stored in a cool, dry place. Potential adverse reactions include skin reactions at the application site, which are usually mild and transient. It is crucial to avoid contact with the eyes and wash hands after handling the product. Additionally, systemic reactions are unlikely due to the low systemic absorption of topically-applied diclofenac sodium. In cases of overdosage, rare but possible adverse effects can occur due to increased absorption of Lidocaine. Consult a medical professional for further information or adverse events.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.